Biocon will distribute insulins and insulin delivery devices through Malaysia’s CCM Pharmaceuticals. Shares of Biocon were trading 2.79 per cent higher at Rs 1,026.30 apiece on BSE.

New Delhi, Jan 25 (PTI) Biotechnology major Biocon has bagged a MYR 300 million (about Rs 460.5 crore) contract from the Ministry of Health, Malaysia to supply recombinant human insulin formulations f ...

Shares of Biocon soared over 4 percent on January 13 after the US Food and Drug Administration cleared arm Biocon Biologics' insulin facility in Malaysia, putting an end to a major regulatory ...

Shares of Biocon Ltd surged as much as 5 per cent during the trading session on Monday after the United States Food and Drug Administration (USFDA) cleared the Malaysia unit, ending regulatory ...